ACE Acetabular Cup 10-year UK post-market follow-up
Official title: A Prospective UK Multi-Centre Post Market Clinical Follow-up Study of the JRI Orthopaedic ACE Acetabular Cup System
Run by JRI Orthopaedics · NCT04123431 · Data updated 2026-11-12
This 10-year follow-up will see how well the ACE Acetabular Cup works and how patients feel after a primary total hip replacement.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 225 (estimated) |
| Sponsor | JRI Orthopaedics Industry-sponsored |
| Locations | 1 site (Worthing) |
| Status | Recruiting |
| Started | June 6, 2023 |
| Main results expected | November 2029 |
| Study ends | November 2035 |
| Registry record updated | September 3, 2025 |
| Trial ID | NCT04123431 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) undergoing elective primary total hip replacement who can give informed consent and will receive the approved ACE Acetabular Cup with a JRI femoral stem and head.
✕Probably not a fit
Patients treated for hip fracture/trauma, those who cannot consent or comply with follow‑up, pregnant patients, or those receiving non‑approved implant combinations are not eligible and would not benefit from this surveillance.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational 10-year post-market surveillance follows adults who receive the CE‑marked ACE Acetabular Cup as part of an elective primary total hip replacement. Data are collected at intervals using patient-reported outcome questionnaires, review of X‑rays, and recording of complications and revisions. The device includes an H‑A.C. coating to promote bone integration and offers ceramic, polymer, or dual‑mobility liners to match surgeon preference. Patients must be able to consent and receive the approved implant combination, and exclusions include trauma cases, pregnancy, or inability to comply with follow-up.
Why it matters
Potential benefit: If successful, the study could confirm long‑term safety and function of the ACE cup and help surgeons and patients choose the best implant.
How similar studies have gone: Previous post‑market registries and studies of coated acetabular cups and dual‑mobility liners generally report good fixation and low revision rates, but device‑specific long‑term data remain important.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients deemed suitable for elective primary THR, as per indications in the IFU. * Male or female, 18 years or older. Exclusion Criteria: * Patients who are unable to provide written informed consent. * Patients deemed unsuitable for THR, as per contra-indications in the IFU. * Patients indicated for THR as a result of trauma (i.e. neck of femur fracture). * Patients who are pregnant (exclusion criteria for THR in general). * Patients receiving implants other than the approved combination, i.e. an ACE Acetabular Cup System with a JRI femoral stem and head. * Patients who are unable to comply with the protocol.
Where it's running
-
University Hospitals Sussex NHS Foundation Trust
Worthing, United Kingdom Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Powered wearable hip exercise device to improve walking and balance in people with hip disease.
We will test whether a powered wearable hip exercise device helps people with hip osteoarthritis or femoral head osteonecrosis walk farther, faster, and with better balance.
-
PENG plus lateral femoral cutaneous nerve block versus lumbar and sacral erector spinae plane blocks for pediatric hip surgery
This trial will test whether combining a PENG block with a lateral femoral cutaneous nerve block gives better pain relief and lowers opioid use than lumbar and sacral erector spinae plane blocks in children aged 2–16 having elective hip surgery.
-
Monitoring the performance of hip implants after surgery
This study looks at how well certain hip implants work and how happy patients are with them after hip surgery over a couple of years.
-
Evaluating the safety and effectiveness of pediatric orthopedic implants
This study is testing how safe and effective orthopedic implants are for kids with fractures and limb deformities to see how they perform over time.
-
Collecting data on Taperloc Complete stems for hip surgeries
This study is trying to see how safe and effective the Taperloc Complete hip implants are for people who have had hip surgery, by looking at both past patients and following new ones over the years.
-
Assessing the safety and performance of SYMBOL medical devices in hip surgeries
This study is testing how safe and effective SYMBOL medical devices are for people having hip surgeries over a 10-year period.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.